Clinical Trial Update: Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate [Phase 2]

View source ↗

Summary

Phase 2 trial of oral magnesium pidolate for Hemoglobin SC disease has been terminated. No efficacy results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemoglobin Sc Disease

Drugs mentioned

• Magnesium pidolate (magnesium pidolate)

Snippet

Sponsor: Baylor College of Medicine | Conditions: HEMOGLOBIN SC DISEASE | Phase 2 | Status: TERMINATED